世界の細胞分析市場動向と予測（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown and Data Triangulation
1.6.3 Key Data Points From Secondary Sources
1.6.4 Key Data Points From Primary Sources
1.6.5 Assumptions

2 Executive Summary (Page No. – 31)

3 Market Overview (Page No. – 34)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Rising Incidences Of Cancer Would Enhance The Cell Analysis Application Market in Diagnosis
3.3.1.2 Corporate & Government Funding and Investments in Cell-Based Research Are Likely to Drive The Market Growth
3.3.1.3 Rising Incidences Of Chronic and Infectious Diseases Would Drive The Market
3.3.1.4 Growing Healthcare Industry and Medical Spending Would Drive The Market Growth
3.3.1.5 Introduction Of Enhanced Informatics Solutions and Improved Image Analysis Instruments
3.3.2 Restraints
3.3.2.1 High Cost Of Cell Analysis Systems Likely to Hinder The Market Growth
3.3.2.2 Complex and Time-Consuming Regulatory Standards to Lengthen The Approval Process
3.3.3 Opportunities
3.3.3.1 Growing APAC Market Would Boost The Cell Analysis Market
3.3.3.2 Contract Research Organizations Have Significant Opportunities to Provide High-Content Screening Services
3.3.3.3 Automation in Cancer Research For Its Early Detection and Reduction in Cost Of Cancer Treatment
3.3.4 Challenges
3.3.4.1 Market Cannibalization Of Existing Technologies By New and Upcoming Technologies
3.3.4.2 Shortage Of Knowledgeable and Skilled Professionals
3.4 Key Players Analysis

4 Global Cell Analysis Market, By Product Type (Page No. – 47)
4.1 Introduction
4.2 Consumables
4.2.1 Reagents
4.2.2 Assay Kits
4.2.2.1 Immunoassays
4.2.2.2 Cell-Based Assays
4.2.3 Microplates
4.2.4 Others Consumables
4.3 Instruments
4.3.1 Microscopes
4.3.1.1 Electron Microscope
4.3.1.2 Inverted Microscopes
4.3.1.3 Stereo Microscopes
4.3.1.4 Fluorescence & Confocal Microscopes
4.3.1.5 Phase Contrast Microscopes
4.3.1.6 Near-Field Scanning Optical Microscopes (Nsom)
4.3.1.7 Other Microscopes
4.3.2 Flow Cytometers
4.3.2.1 Flow Cytometer Instruments
4.3.2.2 Flow Cytometer Software
4.3.3 Spectrophotometers
4.3.3.1 Fluorescence Microplate Readers
4.3.3.2 Microplate Spectrophotometers
4.3.3.3 Colorimeters
4.3.4 QPCR
4.3.5 Microfluidic Devices
4.3.6 Cell Counters
4.3.6.1 Automated Cell Counters
4.3.6.2 Hemocytometers and Manual Cell Counters
4.3.7 High Content Screening (HCS) Systems
4.3.7.1 Cell Imaging and Analysis HCS Systems
4.3.7.2 HCS Software
4.3.8 Cell Microarrays

5 Products Market (Page No. – 91)
5.1 Introduction
5.2 Cell Identification
5.3 Cell Viablity
5.4 Cell Signaling Pathway/Signal Transduction
5.5 Cell Proliferation
5.6 Cell Counting and Quality Control
5.7 Cell Interaction
5.8 Cell Structure Study
5.9 Target Identification and Validation
5.10 Single Cell Analysis

6 Global Cell Analysis Market, By End Users (Page No. – 108)
6.1 Introduction
6.2 Hospitals, Academic, and Research Institutes
6.3 Contract Research Organizations (CROS), and Pharmaceutical and Biotechnology Companies
6.4 Laboratories
6.5 Other End Users

7 Geographic Analysis (Page No. – 118)
7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia-Pacific (APAC)
7.5 ROW

8 Competitive Landscape (Page No. – 173)
8.1 Introduction
8.2 New Product Launches
8.3 Acquisitions
8.4 Agreements, Collaborations, & Partnerships,
8.5 Expansions
8.5.1 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 180)
9.1 Beckton, Dickinson and Company
9.2 Danaher Corporation
9.3 Sigma-Aldrich Corporation
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 GE Healthcare
9.7 Merck KGAA
9.8 Olympus Corpopration
9.9 Perkinelmer, Inc.
9.10 Promega Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case Of Unlisted Companies.

Appendix (Page No. – 230)